Evidence map›Paper›PMID 15201317›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency.

Eugene P Brandon, Tiffany Mellott, Donald P Pizzo, Nicole Coufal, Kevin A D'Amour, Kevin Gobeske, Mark Lortie, Ignacio López-Coviella, Brygida Berse, Leon J Thal and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Central Cholinergic Synapse: A Primer.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Beneficial Effects of Gagam-Palmultang on Scopolamine-Induced Memory Deficits in Mice.Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cholinergic activity as a new target in diseases of the heart.Molecular medicine (Cambridge, Mass.) · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Eugene P BrandonLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.
Tiffany Mellott
Donald P Pizzo
Nicole Coufal
Kevin A D'Amour
Kevin Gobeske
Mark Lortie
Ignacio López-Coviella
Brygida Berse
Leon J Thal
Fred H Gage
Jan Krzysztof Blusztajn
Boston University · USSalk Institute for Biological Studies · USUniversity of California, San Diego · US

Funding

TIME FRAMES OF CHOLINE ENHANCEMENT OF MEMORYP01AG009525 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF · 1991 to 2010
$11.8M
PRE- AND POSTDOCTORAL TRAINING IN BIOCHEMISTRY OF AGINGT32AG000115 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI POLGAR, PETER RUDOLPH · 1985 to 2012
$4.3M
GENE THERAPY OF BASAL FOREBRAIN CHOLINERGIC LESIONSR01AG017533 · NIA · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI THAL, LEON J · 2000 to 2004
$1.4M
BMP actions on cholinergic cellsR01NS042793 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BLUSZTAJN, JAN KRZYSZTOF · 2002 to 2004
$959k
Rapamycin-sensitive pathway of T cell ActivationZ01AG000115 · NIA · NATIONAL INSTITUTE ON AGING · PI LONGO, DAN L. · 2000 to 2008
$762k
Signaling pathways directing cholinergic gene expressionR01NS044238 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BERSE, BRYGIDA · 2002 to 2004
$714k
GENETIC APPROACH TO STUDY ACETYLCHOLINE FUNCTIONSF32GM019519 · NIGMS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI BRANDON, EUGENE P · 1998 to 1999
–
Intramural NIH HHS Z01 AG000115NIA NIH HHS AG00115NIA NIH HHS AG09525NIA NIH HHS AG17533NIA NIH HHS P01 AG009525NIA NIH HHS R01 AG017533NIA NIH HHS T32 AG000115NIGMS NIH HHS F32 GM019519NINDS NIH HHS NS42793NINDS NIH HHS NS44238NINDS NIH HHS R01 NS042793NINDS NIH HHS R01 NS044238
6 · The paper itself

Abstract

Choline acetyltransferase (ChAT), the enzyme that synthesizes the neurotransmitter acetylcholine (ACh), is thought to be present in kinetic excess in cholinergic neurons. The rate-limiting factor in ACh production is the provision of choline to ChAT. Cholinergic neurons are relatively unique in their expression of the choline transporter 1 (CHT1), which exhibits high-affinity for choline and catalyzes its uptake from the extracellular space to the neuron. Multiple lines of evidence indicate that the activity of CHT1 is a key determinant of choline supply for ACh synthesis. We examined the interaction of ChAT and ChT activity using mice heterozygous for a null mutation in the Chat gene (Chat+/-). In these mice, brain ChAT activity was reduced by 40-50% relative to the wild type, but brain ACh levels as well as ACh content and depolarization-evoked ACh release in hippocampal slices were normal. However, the amount of choline taken up by CHT1 and ACh synthesized de novo from choline transported by CHT1 in hippocampal slices, as well as levels of CHT1 mRNA in the septum and CHT1 protein in several regions of the CNS, were 50-100% higher in Chat+/- than in Chat+/+ mice. Thus, haploinsufficiency of ChAT leads to an increased expression of CHT1. Increased ChT activity may compensate for the reduced ChAT activity in Chat+/- mice, contributing to the maintenance of apparently normal cholinergic function as reflected by normal performance of these mice in several behavioral assays.

Indexed as

AcetylcholineAnimalsBehavior, AnimalBiological TransportBrainCholine O-AcetyltransferaseHippocampusIn Vitro TechniquesMembrane Transport ProteinsMiceMice, Mutant StrainsRNA, MessengerSeptum of BrainUp-RegulationAcetylcholineCholine O-AcetyltransferaseCHT1 protein, mouseMembrane Transport ProteinsRNA, Messenger

Identifiers

PMID15201317
PMCPMC6729318
OpenAlexW2101965813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.